Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis-Reference-Cited by-同舟云学术

Bacterial translocation increases phagocytic activity of polymorphonuclear leucocytes in portal hypertension: priming independent of liver cirrhosis

Published:2008-07-25 Issue:8 Volume:28 Page:1149-1157
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:

Author:

Neugebauer Hermann,Hartmann Pia,Krenn Sebastian,Glück Thomas,Schölmerich Jürgen,Straub Rainer,Wiest Reiner

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1478-3231.2008.01829.x/fullpdf

Reference42 articles.

1. A prospective study of bacterial infections in patients with cirrhosis [see comments];Caly;J Hepatol,1993

2. Population-based study of the risk and short-term prognosis for bacteremia in patients with liver cirrhosis;Thulstrup;Clin Infect Dis,2000

3. Impaired opsonization by serum from patients with chronic liver disease;Wyke;Clin Exp Immunol,1983

4. Opsonophagocytic dysfunction in patients with liver cirrhosis and low responses to tumor necrosis factor-alpha and lipopolysaccharide in patients' blood;Ono;J Infect Chemother,2004

5. Decreased leukocyte recruitment in the mesenteric microcirculation of rats with cirrhosis is partially restored by treatment with peginterferon;Geerts;an in vivo study,2007

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical risk factors for portal hypertension-related complications in systemic therapy for hepatocellular carcinoma;Journal of Gastroenterology;2024-04-07

2. Correlation Between Proton Pump Inhibitors and the Complications of Liver Cirrhosis: A Systematic Review and Meta-Analysis;The Turkish Journal of Gastroenterology;2022-01-12

3. Portal hypertension and hepatocellular carcinoma: Des liaisons dangereuses…;Liver International;2021-06-28

4. Chlorophyllin Modulates Gut Microbiota and Inhibits Intestinal Inflammation to Ameliorate Hepatic Fibrosis in Mice;Frontiers in Physiology;2018-12-04

5. Molecular mechanisms of hepatopulmonary syndrome;Fiziolohichnyĭ zhurnal;2017-06-12